Alnylam Pharmaceuticals
ALNY
ALNY
373 hedge funds and large institutions have $16.5B invested in Alnylam Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 74 funds opening new positions, 136 increasing their positions, 109 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
13% more funds holding
Funds holding: 329 → 373 (+44)
1.27% more ownership
Funds ownership: 95.93% → 97.2% (+1.3%)
0% more funds holding in top 10
Funds holding in top 10: 8 → 8 (0)
Holders
373
Holding in Top 10
8
Calls
$154M
Puts
$111M
Top Buyers
| 1 | +$204M | |
| 2 | +$157M | |
| 3 | +$137M | |
| 4 |
American Century Companies
Kansas City,
Missouri
|
+$87.5M |
| 5 |
BlackRock
New York
|
+$81.5M |
Top Sellers
| 1 | -$269M | |
| 2 | -$66.6M | |
| 3 | -$57.7M | |
| 4 |
MC
Maverick Capital
Dallas,
Texas
|
-$33.5M |
| 5 |
AG
Artal Group
Luxembourg
|
-$29.6M |